Creating a tool to analyze emergency department records using language processing
Development and Validation of a Natural Language Processing Tool to Enable Clinical Research in Emergency and Acute Care Medicine: Retrospective Cohort Study
This study is testing a new tool that uses language processing to help understand and analyze emergency department records, making it easier for researchers to gather important information from patient visits.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Mario Negri Institute for Pharmacological Research Academic / other |
| Locations | 8 sites (Milan, Milan and 7 other locations) |
| Trial ID | NCT06240572 on ClinicalTrials.gov |
What this trial studies
This observational study aims to develop and validate a natural language processing (NLP) tool that can interpret electronic medical records from emergency departments. By automatically extracting relevant information from free text in these records, the study seeks to facilitate clinical research and quality assessments in emergency medicine. The retrospective cohort study will analyze data from adult patients who visited participating emergency departments over a three-year period, focusing on the tool's ability to accurately interpret and extract necessary information for research purposes.
Who should consider this trial
Good fit: Ideal candidates for this study are adults who arrived at emergency departments between January 1, 2021, and December 31, 2023.
Not a fit: Patients who did not visit the emergency department during the specified time frame will not benefit from this study.
Why it matters
Potential benefit: If successful, this tool could significantly enhance the ability to conduct research in emergency medicine, leading to improved patient care based on evidence derived from real-world data.
How similar studies have performed: Other studies utilizing natural language processing in healthcare have shown promise, indicating that this approach could be effective in the medical domain.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult * Arrived at emergency department between 1 January 2021 and 31 December 2023 Exclusion Criteria: * None
Where this trial is running
Milan, Milan and 7 other locations
- Istituto di Ricerche Farmacologiche Mario Negri IRCCS — Milan, Milan, Italy (Not_yet_recruiting)
- AOU Policlinico 'G.Rodolico - San Marco' — Catania, Italy (Not_yet_recruiting)
- ASST Grande Ospedale Metropolitano Niguarda — Milan, Italy (Not_yet_recruiting)
- Ospedale Luigi Sacco — Milan, Italy (Not_yet_recruiting)
- Ospedale San Luigi Gonzaga — Orbassano, Italy (Not_yet_recruiting)
- Ospedale Santa Maria delle Grazie — Pozzuoli, Italy (Not_yet_recruiting)
- Ospedale San Giovanni Bosco — Torino, Italy (Recruiting)
- Ospedale Sant'Andrea — Vercelli, Italy (Not_yet_recruiting)
Study contacts
- Principal investigator: Guido Bertolini — Istituto Di Ricerche Farmacologiche Mario Negri
- Study coordinator: Chiara Pandolfini
- Email: chiara.pandolfini@marionegri.it
- Phone: 0039 02 39014 253
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.